Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug targets
Research
Mitochondrial free radicals spur micronuclear collapse in cancer
Two studies explain in mechanistic detail how micronuclei rupture and collapse in cancer cells, an important process that drives cancer progression.
Darren Incorvaia
Aug 29, 2024 2:00pm
Boehringer bets $509M on Phenomic's AI tech to reach tumors
Nov 29, 2023 8:00am
Takeda puts $510M on the line to expand KSQ cancer collaboration
May 17, 2023 9:35am
Ginkgo, Boehringer Ingelheim team up on $406M discovery pact
May 8, 2023 7:00am
Flagship fledging fetches $50M to fire drugs at specific organs
Mar 7, 2023 9:15am
How Amgen, AZ's Tezspire holds promise for colorectal cancer
May 18, 2022 2:00pm
